{"id":"https://openalex.org/W2048025540","doi":"https://doi.org/10.1046/j.1365-2141.2001.02883.x","title":"A phase II trial of pirfenidone (5\u2010methyl\u20101\u2010phenyl\u20102\u2010[1H]\u2010pyridone), a novel anti\u2010fibrosing agent, in myelofibrosis with myeloid metaplasia","display_name":"A phase II trial of pirfenidone (5\u2010methyl\u20101\u2010phenyl\u20102\u2010[1H]\u2010pyridone), a novel anti\u2010fibrosing agent, in myelofibrosis with myeloid metaplasia","publication_year":2001,"publication_date":"2001-07-01","ids":{"openalex":"https://openalex.org/W2048025540","doi":"https://doi.org/10.1046/j.1365-2141.2001.02883.x","mag":"2048025540","pmid":"https://pubmed.ncbi.nlm.nih.gov/11472354"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2141.2001.02883.x","doi":"https://doi.org/10.1046/j.1365-2141.2001.02883.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2141.2001.02883.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039057642","display_name":"Ruben A. Mesa","orcid":"https://orcid.org/0000-0001-5880-7972","observed_orcids":["https://orcid.org/0000-0001-5880-7972"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruben A. Mesa","raw_affiliation_strings":["Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA","Division of Hematology and Internal Medicine,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Division of Hematology and Internal Medicine,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016216479","display_name":"Ayalew Tefferi","orcid":"https://orcid.org/0000-0003-4605-3821","observed_orcids":["https://orcid.org/0000-0003-4605-3821"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ayalew Tefferi","raw_affiliation_strings":["Division of Hematology and Internal Medicine,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Internal Medicine,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064374340","display_name":"Michelle Ann Elliott","orcid":"https://orcid.org/0000-0002-7366-9886","observed_orcids":["https://orcid.org/0000-0002-7366-9886"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle A. Elliott","raw_affiliation_strings":["Division of Hematology and Internal Medicine,","Mayo Clinic Rochester-MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Internal Medicine,","institution_ids":[]},{"raw_affiliation_string":"Mayo Clinic Rochester-MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111843365","display_name":"H. Clark Hoagland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Clark Hoagland","raw_affiliation_strings":["Division of Hematology and Internal Medicine,","Mayo Clinic Rochester-MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Internal Medicine,","institution_ids":[]},{"raw_affiliation_string":"Mayo Clinic Rochester-MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051752737","display_name":"Timothy G. Call","orcid":"https://orcid.org/0000-0002-8465-9587","observed_orcids":["https://orcid.org/0000-0002-8465-9587"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy G. Call","raw_affiliation_strings":["Division of Hematology and Internal Medicine,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Internal Medicine,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025859771","display_name":"Georgene S. Schroeder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Georgene S. Schroeder","raw_affiliation_strings":["Cancer Center Statistics Unit, and","Mayo Clinic Rochester-MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center Statistics Unit, and","institution_ids":[]},{"raw_affiliation_string":"Mayo Clinic Rochester-MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101878788","display_name":"Soo\u2010Young Yoon","orcid":"https://orcid.org/0000-0002-0066-5390","observed_orcids":["https://orcid.org/0000-0002-0066-5390"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Soo\u2010Young Yoon","raw_affiliation_strings":["Division of Hematopathology, Mayo Clinic, Rochester, MN, and","Mayo Clinic Rochester-MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematopathology, Mayo Clinic, Rochester, MN, and","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Mayo Clinic Rochester-MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111801384","display_name":"Chin\u2010Yang Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chin\u2010Yang Li","raw_affiliation_strings":["Division of Hematopathology, Mayo Clinic, Rochester, MN, and","Mayo Clinic Rochester-MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematopathology, Mayo Clinic, Rochester, MN, and","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Mayo Clinic Rochester-MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010422032","display_name":"Leigh A. Gray","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leigh A. Gray","raw_affiliation_strings":["Division of Hematology and Internal Medicine,","Mayo Clinic Rochester-MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Internal Medicine,","institution_ids":[]},{"raw_affiliation_string":"Mayo Clinic Rochester-MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014547351","display_name":"Solomon B. Margolin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Margolin","raw_affiliation_strings":["Marnac Inc., Dallas, TX, USA","Marnac Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marnac Inc., Dallas, TX, USA","institution_ids":[]},{"raw_affiliation_string":"Marnac Inc","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013866554","display_name":"C. Christopher Hook","orcid":"https://orcid.org/0000-0002-3971-6183","observed_orcids":["https://orcid.org/0000-0002-3971-6183"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"C. Christopher Hook","raw_affiliation_strings":["Division of Hematology and Internal Medicine,","Mayo Clinic Rochester-MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Internal Medicine,","institution_ids":[]},{"raw_affiliation_string":"Mayo Clinic Rochester-MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5013866554"],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":1.7588,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.86890323,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"114","issue":"1","first_page":"111","last_page":"113"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13374","display_name":"Hematological disorders and diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pirfenidone","display_name":"pirfenidone","score":1.0},{"id":"https://openalex.org/keywords/myelofibrosis-with-myeloid-metaplasia","display_name":"myelofibrosis with myeloid metaplasia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/antifibrotic-therapy","display_name":"antifibrotic therapy","score":0.9039999842643738},{"id":"https://openalex.org/keywords/cytokine-modulation","display_name":"cytokine modulation","score":0.7799999713897705},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.656000018119812},{"id":"https://openalex.org/keywords/splenomegaly","display_name":"splenomegaly","score":1.0},{"id":"https://openalex.org/keywords/bone-marrow-morphology","display_name":"bone marrow morphology","score":0.8149999976158142},{"id":"https://openalex.org/keywords/drug-intolerance","display_name":"drug intolerance","score":0.5490000247955322},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.935312807559967},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.898907482624054},{"id":"https://openalex.org/C2779832356","wikidata":"https://www.wikidata.org/wiki/Q2060696","display_name":"Pirfenidone","level":4,"score":0.8835651874542236},{"id":"https://openalex.org/C2779357193","wikidata":"https://www.wikidata.org/wiki/Q660713","display_name":"Metaplasia","level":2,"score":0.6790656447410583},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6160587072372437},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5799318552017212},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5373598337173462},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.514046311378479},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4251355230808258},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4212711751461029},{"id":"https://openalex.org/C2777753580","wikidata":"https://www.wikidata.org/wiki/Q1441305","display_name":"Constitutional symptoms","level":3,"score":0.41132447123527527},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3726407587528229},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.331114262342453},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.3181402087211609},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.09237745404243469},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.0825357437133789}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000933","descriptor_name":"Antifibrinolytic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1365-2141.2001.02883.x","doi":"https://doi.org/10.1046/j.1365-2141.2001.02883.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2141.2001.02883.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:11472354","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11472354","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W246907960","https://openalex.org/W1493760002","https://openalex.org/W1966343588","https://openalex.org/W1987827515","https://openalex.org/W2008647897","https://openalex.org/W2067459103","https://openalex.org/W2069811721","https://openalex.org/W2083890832","https://openalex.org/W2163147529","https://openalex.org/W2326795317","https://openalex.org/W3114368461","https://openalex.org/W4406056548"],"related_works":["https://openalex.org/W2587638402","https://openalex.org/W2015022511","https://openalex.org/W2563730090","https://openalex.org/W2096816874","https://openalex.org/W2109680888","https://openalex.org/W2569690486","https://openalex.org/W2979827561","https://openalex.org/W2091165956","https://openalex.org/W2992387965","https://openalex.org/W2282103947"],"abstract_inverted_index":{"The":[0,67],"anti-fibrotic":[1],"and":[2,47,65],"cytokine":[3],"modulatory":[4],"properties":[5],"of":[6,14,38,44,50,70,84],"pirfenidone":[7,90],"suggest":[8],"its":[9],"usefulness":[10],"in":[11,78,98],"the":[12,79,85],"treatment":[13],"myelofibrosis":[15],"with":[16,26,30,61,74],"myeloid":[17],"metaplasia":[18],"(MMM).":[19],"In":[20],"a":[21,57],"prospective":[22],"study,":[23],"28":[24],"patients":[25,34],"MMM":[27],"were":[28,41],"treated":[29],"oral":[31],"pirfenidone.":[32],"Twelve":[33],"completed":[35],"1":[36],"year":[37],"therapy;":[39],"13":[40],"withdrawn":[42],"because":[43,49],"disease":[45],"progression":[46],"three":[48],"drug":[51],"intolerance.":[52],"Only":[53],"one":[54],"patient":[55],"experienced":[56],"clinically":[58],"relevant":[59],"benefit":[60,72],"respect":[62],"to":[63],"anaemia":[64],"splenomegaly.":[66],"overall":[68],"lack":[69],"clinical":[71,94],"correlated":[73],"no":[75,92],"significant":[76,93],"improvement":[77],"bone":[80],"marrow":[81],"morphological":[82],"features":[83],"disease.":[86],"We":[87],"conclude":[88],"that":[89],"has":[91],"or":[95],"biological":[96],"activity":[97],"MMM.":[99]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}